Validation of an Updated 51-Gene Hybrid-Capture NGS Assay for Myeloid Neoplasms: Improved Variant Detection and Laboratory Efficiency
Michigan Medical Education and Health Bulletin · 29.06.2026 · 4 (2 (supplement))
DOI: 10.69735/001c.163877 ↗Kurz gefasst
Fachartikel in der Zeitschrift Michigan Medical Education and Health Bulletin, online erschienen am 29.06.2026. Verfasst von Hillary Smith und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Smith, H., Luong, S., Skowron, A., & Carr, D. (2026). Validation of an Updated 51-Gene Hybrid-Capture NGS Assay for Myeloid Neoplasms: Improved Variant Detection and Laboratory Efficiency. Michigan Medical Education and Health Bulletin, 4(2 (supplement)). https://doi.org/10.69735/001c.163877
Vancouver
Smith H, Luong S, Skowron A, Carr D. Validation of an Updated 51-Gene Hybrid-Capture NGS Assay for Myeloid Neoplasms: Improved Variant Detection and Laboratory Efficiency. Michigan Medical Education and Health Bulletin. 2026;4(2 (supplement)). doi:10.69735/001c.163877
BibTeX
@article{Smith2026,
author = {Smith, Hillary and Luong, Susanna and Skowron, Alexandra and Carr, David},
title = {Validation of an Updated 51-Gene Hybrid-Capture NGS Assay for Myeloid Neoplasms: Improved Variant Detection and Laboratory Efficiency},
journal = {Michigan Medical Education and Health Bulletin},
year = {2026},
volume = {4},
number = {2 (supplement)},
doi = {10.69735/001c.163877}
}
EUVIMED